Mucosa‐associated lymphoid tissue lymphoma translocation protein 1 (MALT1) is a key adaptor protein that regulates the NF‐κB pathway, in which MALT1 functions as a scaffold protein and protease to trigger downstream signals. The abnormal expression of MALT1 is closely associated with lymphomagenesis and other diseases, including solid tumors and autoimmune diseases. MALT1 is the only protease in the underlying pathogenesis of these diseases, and its proteolytic activity can be pharmacologically regulated. Therefore, MALT1 is a potential and promising target for anti‐lymphoma and other MALT1‐related disease treatments. Currently, the development of MALT1 inhibitors is still in its early stages. This review presents an overview of MALT1, particularly its X‐ray structures and biological functions, and elaborates on the pathogenesis of diseases associated with its dysregulation. We then summarize previously reported MALT1 inhibitors, focusing on their molecular structure, biological activity, structure–activity relationship, and limitations. Finally, we propose future research directions to accelerate the discovery of novel MALT1 inhibitors with clinical applications. Overall, this review provides a comprehensive and systematic overview of MALT1‐related research advances and serves as a theoretical basis for drug discovery and research.
Development
of mucosa-associated lymphoid tissue lymphoma translocation
protein 1 (MALT1) inhibitors is of great value and significance in
the treatment of neoplastic disorders and inflammatory and autoimmune
diseases. However, there is a lack of effective MALT1 inhibitors in
clinic. Herein, a novel class of potent 5-oxo-1-thioxo-4,5-dihydro-1H-thiazolo[3,4-a]quinazoline-based MALT1
inhibitors and their covalent derivatives were first identified and
designed through high-throughput screening. We demonstrated that compounds 15c, 15e, and 20c effectively inhibited
the MALT1 protease and displayed selective cytotoxicity to activated
B cell-like diffuse large B cell lymphoma with low single-digit micromolar
potency. Furthermore, compound 20c specifically repressed
NF-κB signaling and induced cell apoptosis in MALT1-dependent
TMD8 cells in a dose-dependent manner. More importantly, 20c showed good pharmacokinetic properties and antitumor efficacy with
no significant toxicity in the TMD8 xenograft tumor model. Collectively,
this study provides valuable lead compounds of MALT1 inhibitors for
further structural optimization and antitumor mechanism study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.